1. Home
  2. MC vs ICUI Comparison

MC vs ICUI Comparison

Compare MC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MC
  • ICUI
  • Stock Information
  • Founded
  • MC 2007
  • ICUI 1984
  • Country
  • MC United States
  • ICUI United States
  • Employees
  • MC N/A
  • ICUI N/A
  • Industry
  • MC Investment Managers
  • ICUI Medical/Dental Instruments
  • Sector
  • MC Finance
  • ICUI Health Care
  • Exchange
  • MC Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • MC 4.1B
  • ICUI 4.0B
  • IPO Year
  • MC 2014
  • ICUI 1992
  • Fundamental
  • Price
  • MC $69.33
  • ICUI $176.46
  • Analyst Decision
  • MC Sell
  • ICUI Buy
  • Analyst Count
  • MC 7
  • ICUI 4
  • Target Price
  • MC $58.33
  • ICUI $149.00
  • AVG Volume (30 Days)
  • MC 617.7K
  • ICUI 217.6K
  • Earning Date
  • MC 10-31-2024
  • ICUI 11-04-2024
  • Dividend Yield
  • MC 3.45%
  • ICUI N/A
  • EPS Growth
  • MC N/A
  • ICUI N/A
  • EPS
  • MC 0.19
  • ICUI N/A
  • Revenue
  • MC $969,128,000.00
  • ICUI $2,304,277,000.00
  • Revenue This Year
  • MC $31.27
  • ICUI $3.80
  • Revenue Next Year
  • MC $25.13
  • ICUI $4.01
  • P/E Ratio
  • MC $360.40
  • ICUI N/A
  • Revenue Growth
  • MC 19.89
  • ICUI 0.46
  • 52 Week Low
  • MC $38.58
  • ICUI $78.28
  • 52 Week High
  • MC $70.06
  • ICUI $181.87
  • Technical
  • Relative Strength Index (RSI)
  • MC 63.74
  • ICUI 73.26
  • Support Level
  • MC $61.41
  • ICUI $160.74
  • Resistance Level
  • MC $65.76
  • ICUI $167.78
  • Average True Range (ATR)
  • MC 1.88
  • ICUI 5.31
  • MACD
  • MC 0.26
  • ICUI 0.36
  • Stochastic Oscillator
  • MC 91.56
  • ICUI 76.24

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: